Concepedia

Stephen M. Condon

SM

Statistics

Publications

33

Citations

3.7K

H-Index

24

Active since

1980

Affiliations

TetraLogic Pharmaceuticals (United States)(Current)

The University of Melbourne

Walter and Eliza Hall Institute of Medical Research

La Trobe University

University of Pennsylvania

Stephen M. Condon is an author at TetraLogic Pharmaceuticals (United States) specializing in pharmacology, medicinal chemistry, and apoptosis.

Publications per year

1980–2017

33

Publications

33

IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis

James E. Vince, W. Wei‐Lynn Wong, Nufail Khan et al. · Cell · 2007 · 1.1K citations · Full text

Life Sciences, Cell Biology, Immunology +14

RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL

Kate E. Lawlor, Nufail Khan, Alison Mildenhall et al. · Nature Communications · 2015 · 641 citations · Full text

Life Sciences, Immunology, Pathology +17

TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1–TRAF2 complex to sensitize tumor cells to TNFα

James E. Vince, Diep Chau, Bernard A. Callus et al. · The Journal of Cell Biology · 2008 · 237 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia

Gabriela Brumatti, Chunyan Ma, Najoua Lalaoui et al. · Science Translational Medicine · 2016 · 186 citations

Medicine, Cancer Biology, Oncology +17

Birinapant (TL32711), a Bivalent SMAC Mimetic, Targets TRAF2-Associated cIAPs, Abrogates TNF-Induced NF-κB Activation, and Is Active in Patient-Derived Xenograft Models

Christopher A. Benetatos, Yasuhiro Mitsuuchi, Jennifer M. Burns et al. · Molecular Cancer Therapeutics · 2014 · 175 citations

Life Sciences, Oncology, Pharmacology +17

1–5 of 33